Back to Market返回行情
SC
SCIB.ST SciBase Holding AB (publ)
STOHealthcare$42.20+9383.15%OpenMarket Cap: $431.5M
As of 2026-06-04 10:41
Valuation
P/E (TTM)
-374.53
PEG
—
P/B
613.60
P/S
389.64
EV/EBITDA
-234.59
DCF Value
—
FCF Yield
-0.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
58.6%
Operating Margin
-197.6%
Net Margin
-207.5%
ROE
-291.7%
ROA
-91.8%
ROIC
-110.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $14.3M | 49.2% | $-24.2M | $-24.5M | $-2.99 | — |
| Q4 2025 | $12.5M | 63.0% | $-26.4M | $-25.3M | $-5.09 | — |
| Q3 2025 | $10.3M | 60.0% | $-17.7M | $-18.8M | $-5.00 | — |
| Q2 2025 | $8.8M | 66.2% | $-22.4M | $-26.6M | $-7.86 | — |
| Q1 2025 | $8.9M | 70.5% | $-19.6M | $-27.5M | $-9.21 | — |
| Q4 2024 | $8.6M | 68.5% | $-23.6M | $-17.5M | $-7.95 | — |
| Q3 2024 | $8.4M | 75.7% | $-14.6M | $-17.8M | $-8.09 | — |
| Q2 2024 | $6.6M | 69.1% | $-14.7M | $-15.1M | $-8.08 | — |
| Q1 2024 | $6.1M | 69.9% | $-14.3M | $-10.9M | $-9.06 | — |
| Q4 2023 | $5.8M | 73.5% | $-16.7M | $-20.5M | $-17.00 | — |
| Q3 2023 | $7.2M | 68.2% | $-12.7M | $-12.8M | $-11.00 | — |
| Q2 2023 | $5.1M | 65.3% | $-13.8M | $-11.4M | $-16.00 | — |